CommentaryHPV, vaccines, and cervical cancer in a low- and middle-income country
Section snippets
Author statement
Lauren M. Petersen: Methodology, Investigation, Data curation; Jamie M. Fenton: Investigation, Data curation; Linda S. Kennedy: Conceptualization, Writing- Review and editing, Funding acquisition; Ethan P.M. LaRochelle: Formal analysis, Writing-reviewing and editing; Suyapa Bejarano: Resources, Writing-reviewing and editing; Gregory J. Tsongalis: Conceptualization, Supervision, Writing-original draft, Project administration.
Acknowledgments
The authors acknowledge the support of the Pathology Shared Resource, a section of the Laboratory for Clinical Genomics and Advanced Technology, in the Department of Pathology and Laboratory Medicine of the Dartmouth Hitchcock Health System and the Norris Cotton Cancer Center at Dartmouth with NCI Cancer Center Support Grant 5P30 CA023108-37.
References (4)
- et al.
Estimates of incidence and mortality of cervical cancer in 2018:a worldwide analysis
Lancet Glob Health
(2020) - et al.
Rural distribution of human papilloma virus in low- and middle-income countries
Exp Mol Pathol
(2018)
Cited by (5)
Providing Diagnostic Pathology Services in Low and Middle-Income Countries
2024, Hematology/Oncology Clinics of North AmericaGenetic diversity of human papillomavirus (HPV) as specified by the detection method, gender, and year of sampling: a retrospective cross-sectional study
2023, Archives of Gynecology and ObstetricsLiving the best of both worlds: A personal scientific journey
2022, FASEB BioAdvances
Declaration of Competing Interest: The authors have no conflict of interest to declare.